glp-1 agonist therapy consultation preparation Patient Counseling: Balancing Evidence and Expectations Peptide GLP-1 receptor agonists: From

A meta-analysis of 12 studies (that included ten cohort and two case-control studies) found no overall change in PDAC risk amongst GLP-1RA users

If the body reacts to the new peptide with nausea or fatigue, sleeping through the initial response means less disruption to daily activities

About this article Cite this article Giugliano, D., Scappaticcio, L., Longo, M

GLP-1based therapy is also mentioned in the 2026 ADA Standards of Care as part of risk-based treatment options for many adults with type 2 diabetes

Dual GLP-1/glucagon receptor agonists, including mazdutide, integrate appetite suppression with increased energy expenditure and fat oxidation, while triple GLP-1/GIP/glucagon agonists, such as retatrutide, further augment these mechanisms through multi-pathway receptor engagement

Moon JS, Hong JH, Jung YJ, Ferrannini E, Nauck MA, Lim S